Spastic Diplegia in a Haitian Girl with Angelman Syndrome

Abstract

Spastic diplegia, a muscle hypertonia motor syndrome, can occur in conjunction with the characteristic abnormal movement features of Angelman syndrome (AS), a neurodevelopmental disorder with primary features of ataxic gait, happy demeanor, developmental delay, speech impairment, intellectual disability, microcephaly, and seizures. Spastic diplegia is classically associated with cerebral palsy (CP), an umbrella term encompassing developmental delay, abnormal brain magnetic resonance imaging findings, and various types of CP including spastic, ataxic, dyskinetic, and mixed types. We present a 12-year-old Haitian patient of African descent with AS due to a microdeletion involving the entire UBE3A (ubiquitin-protein ligase E3A) gene and spastic diplegia. She was initially given a clinical diagnosis of CP. Cases of AS in patients of African descent have been rarely reported and this case of severe spastic diplegia, unresponsive to medical intervention, reflects a rarely reported presentation of AS in patients of African descent and possibly the first reported case of a Haitian patient with this clinical presentation. Given that deletions are the most common mechanism resulting in AS, this case report provides supportive evidence that chromosome 15q11 deletion-type AS is most frequently associated with spastic diplegia, a more severe motor impairment phenotype in AS.

Keywords

Angelman syndrome - UBE3A - spastic diplegia

• References

• 1 Aguilera C, Viñas-Jornet M, Baena N. , et al. Novel intragenic deletions within the UBE3A gene in two unrelated patients with Angelman syndrome: case report and review of the literature. BMC Med Genet 2017; 18 (01) 137
• 2 Willams CA, Beaudet AL, Clayton-Smith J. , et al. Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A 2006; 140 (05) 413-418
• 3 Huntsman R, Lemire E, Norton J, Dzus A, Blakley P, Hasal S. The differential diagnosis of spastic diplegia. Arch Dis Child 2015; 100 (05) 500-504
• 4 Dan B, Bouillot E, Bengoetxea A, Boyd SG, Cheron G. Distinct multi-joint control strategies in spastic diplegia associated with prematurity or Angelman syndrome. Clin Neurophysiol 2001; 112 (09) 1618-1625
• 5 Buiting K, Williams C, Horsthemke B. Angelman syndrome - insights into a rare neurogenetic disorder. Nat Rev Neurol 2016; 12 (10) 584-593
• 6 Dagli A, Buiting K, Williams CA. Molecular and clinical aspects of Angelman syndrome. Mol Syndromol 2012; 2 (3-5): 100-112
• 7 Beckung E, Steffenburg S, Kyllerman M. Motor impairments, neurological signs, and developmental level in individuals with Angelman syndrome. Dev Med Child Neurol 2004; 46 (04) 239-243
• 8 Sahoo T, Bacino CA, German JR. , et al. Identification of novel deletions of 15q11q13 in Angelman syndrome by array-CGH: molecular characterization and genotype-phenotype correlations. Eur J Hum Genet 2007; 15 (09) 943-949
• 9 Molfetta GA, Muñoz MV, Santos AC, Silva Jr WA, Wagstaff J, Pina-Neto JM. Discordant phenotypes in first cousins with UBE3A frameshift mutation. Am J Med Genet A 2004; 127A [phone]
• 10 Online Mendelian Inheritance in Man. OMIM ^®. Johns Hopkins University, Baltimore, MD. MIM Number: {608145}. Available at: https://omim.org/ . Accessed March 5, 2018
• 11 Reed JA, Wilkinson PA, Patel H. , et al. A novel NIPA1 mutation associated with a pure form of autosomal dominant hereditary spastic paraplegia. Neurogenetics 2005; 6 (02) 79-84
• 12 Meng L, Person RE, Huang W, Zhu PJ, Costa-Mattioli M, Beaudet AL. Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse model. PLoS Genet 2013; 9 (12) e1004039
• 13 DuBose AJ, Johnstone KA, Smith EY, Hallett RA, Resnick JL. Atp10a, a gene adjacent to the PWS/AS gene cluster, is not imprinted in mouse and is insensitive to the PWS-IC. Neurogenetics 2010; 11 (02) 145-151
• 14 Hogart A, Patzel KA, LaSalle JM. Gender influences monoallelic expression of ATP10A in human brain. Hum Genet 2008; 124 (03) 235-242